"10.1371_journal.pone.0137666","plos one","2015-09-14T00:00:00Z","Zoe Moodie; Barbara Metch; Linda-Gail Bekker; Gavin Churchyard; Maphoshane Nchabeleng; Koleka Mlisana; Fatima Laher; Surita Roux; Kathryn Mngadi; Craig Innes; Matsontso Mathebula; Mary Allen; Carter Bentley; Peter B Gilbert; Michael Robertson; James Kublin; Lawrence Corey; Glenda E Gray","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa; Aurum Institute for Health Research, Johannesburg, South Africa; School of Public Health, University of Witwatersrand, Johannesburg, South Africa; London School of Hygiene and Tropical Medicine, London, United Kingdom; Mecru Clinical Research Unit, Sefako Makgatho Health Sciences University, Pretoria, South Africa; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal and National Health Laboratory Service, Durban, South Africa; Perinatal HIV Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa; Aurum Institute Clinical Research Site, Klerksdorp, South Africa; Vaccine Research Program, Division of AIDS, NIAID, NIH, Rockville, United States of America; Merck Research Laboratories, West Point, Pennsylvania, United States of America; South African Medical Research Council, Cape Town, South Africa","Conceived and designed the experiments: ZM BM LGB GC MN K. Mngadi FL SR K. Mlisana CI MM MA CB PBG MR JK LC GEG. Performed the experiments: ZM BM LGB GC MN K. Mngadi FL SR K. Mlisana CI MM MA CB PBG MR JK LC GEG. Analyzed the data: ZM BM. Wrote the paper: ZM BM MA GEG JK LC CB.","The authors have read the journal's policy and the authors of this manuscript have the following competing interests: MA is employed by the National Institute of Allergy and Infectious Diseases (NIAID), the study sponsor. All authors are current recipients of NIAID funding, and this publication is a result of activities funded by NIAID. MA was not involved with the process of funding these awards, nor in their administration or scientific aspects, and, in accordance with NIAID policies, is deferred from decisions regarding funding of coauthors for a requisite period. This study was also partly funded by Merck and Co Inc. Michael Robertson is an employee of and owns stock in Merck Research Laboratories. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","09","Zoe Moodie","ZM",18,TRUE,6,6,2,7,TRUE,TRUE,TRUE,6,"7;8;10;11;14;15",TRUE
